A role for IL‐4 in immunologically mediated enteropathy

A role for IL‐4 in immunologically mediated enteropathy
复制标题

IL-4 在免疫介导的肠病中的作用

DOI:
10.1111/j.1365-2249.1995.tb03473.x
复制
发表时间:
1995
影响因子:
4.6
通讯作者:
M. Widmer
M. Widmer
中科院分区:
医学3区
文献类型:
--
作者:
A. Mowat;M. Widmer

文献摘要

参考文献

被引文献

相似文献

许多临床肠病与局部细胞免疫(CMI)反应有关,实验证据表明细胞因子与肠道病理有关。我们在这里表明,用单抗或IL-4受体(IL-4R)的可溶性形式去除IL-4可以防止以隐窝增生和上皮内淋巴细胞(IEL)募集为特征的增殖型小鼠移植物抗宿主反应(GVHR)的空肠表现。在GVHR破坏性模型中,去除IL-4不能阻止绒毛萎缩的出现,也不影响系统免疫的任何指标。这些结果表明,IL-4可能在肠道免疫病理的增殖性方面发挥选择性作用,并提示该细胞因子可能为免疫治疗提供一个有用的靶点。
A number of clinical enteropathies are associated with a local cell‐mediated immune (CMI) response, and experimental evidence indicates that cytokines are responsible for the intestinal pathology. We show here that depletion of IL‐4 using MoAb or a soluble form of the IL‐4 receptor (IL‐4R) prevents the jejunal manifestations of a proliferative form of murine graft‐versus‐host reaction (GVHR) characterized by crypt hyperplasia and recruitment of intraepithelial lymphocytes (IEL). Depletion of IL‐4 did not prevent the appearance of villus atrophy in a destructive model of GVHR, and had no effect on any indices of systemic immunity. These results indicate that IL‐4 may play a selective role in mediating proliferative aspects of intestinal immunopathology, and suggest that this cytokine may provide a useful target for immunotherapy.
DOI: 10.1182/blood.v78.8.1915.1915
发表时间: 1991-10
期刊: Blood
影响因子: 20.3
作者:
P. McCarthy;S. Abhyankar;S. Neben;Gale D. Newman;C. Sieff;R. Thompson;Steven;-J.;Burakoff
通讯作者: P. McCarthy;S. Abhyankar;S. Neben;Gale D. Newman;C. Sieff;R. Thompson;Steven;-J.;Burakoff
DOI: --
发表时间: 1993
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者:
Ballas,ZK;Rasmussen,W
通讯作者: Rasmussen,W